Refining the assessment of the sensitivity and specificity of diagnostic tests, with applications to prostate cancer screening and non-small cell lung cancer staging.
Berger
Vance W
VW
Biometry Research Group, National Cancer Institute/NIH, Executive Plaza North, Suite 3131, 6130 Executive Boulevard, MSC 7354, Bethesda, MD 20892-7354, USA. vb78c@nih.gov
Semanick
Lisa
L
D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis*; D003955:Diagnostic Tests, Routine; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D008297:Male; D008403:Mass Screening / Q000379:methods*; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000276:immunology*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D017430:Prostate-Specific Antigen